Formulation and product adaptation
Evaluating how an existing or new product can be formulated, transferred or adapted for the intended dosage form, market and manufacturing environment.
Innovation with a Practical Purpose
For Jean Vichar, innovation means applying technology, process knowledge and partnership models to move valuable pharmaceutical products toward reliable commercial supply.
REF. JV-INNOV-001OUR APPROACH
Innovation is not a slogan or a separate department. It is the disciplined work of improving how products are developed, transferred, manufactured and supplied.
Jean Vichar focuses on opportunities where new capabilities or better coordination can create practical value: establishing manufacturing platforms, transferring products into local production, improving processes, supporting specialized drug-delivery technologies and connecting international pharmaceutical partners with domestic execution.
Every opportunity begins with evidence. The product need, technical feasibility, intellectual-property position, regulatory pathway, component availability, market context and manufacturing fit must be understood before resources are committed.
REF. JV-FOCUS-002WHERE INNOVATION HAPPENS
Evaluating how an existing or new product can be formulated, transferred or adapted for the intended dosage form, market and manufacturing environment.
Understanding material and process behavior, defining operating ranges and improving repeatability, efficiency and manufacturability.
Building capability across oral solid dosage, metered-dose inhalers, nasal sprays and, through Lirok Pharma, dry powder inhalers.
Working with product owners, API manufacturers and technology partners to translate established knowledge into controlled local manufacture.
Strengthening the systems that make technical decisions traceable and allow processes to be reviewed, validated and improved.
Using the group’s sourcing, manufacturing, inhalation and distribution capabilities to reduce fragmented handoffs across the product lifecycle.
REF. JV-EVAL-003OPPORTUNITY EVALUATION
A project must make sense technically, operationally and commercially before it becomes a development program.
Clarify the patient, market or supply problem and the benefit the proposed product or technology is expected to provide.
Review formulation status, dosage form, API and component requirements, available data, regulatory pathway and manufacturing compatibility.
Define technical work, responsibilities, decision gates, documentation, scale-up requirements, risk controls and expected outcomes.
Connect development activity to validation, registration support, supply planning, packaging and distribution rather than treating R&D as an isolated endpoint.
REF. JV-COLLAB-004COLLABORATION
Jean Vichar welcomes structured collaboration with API manufacturers, pharmaceutical companies, formulation specialists, technology owners and device or packaging partners.
A productive collaboration begins with clear information and realistic expectations. We assess what knowledge already exists, what must be generated, what the partner will provide and what Jean Vichar must establish locally. Confidentiality, intellectual-property responsibilities, development ownership and commercialization objectives should be addressed early.
Where the opportunity aligns with our platforms and strategy, collaboration can extend from feasibility and formulation through technology transfer, validation, registration support, commercial manufacturing and lifecycle management.